ONYCHOMYCOSIS DRUG EFFICACY BASED ON CLINICAL ENDPOINTS, NOT MYCOLOGICAL CULTURING OF NAIL FUNGUS, IS ACCEPTABLE FOR APPROVAL, FDA COMMITTEE CONCLUDES
Executive Summary
Treatment success of drugs for nail fungus (onychomycosis) can be defined by clinical parameters only and does not require a negative mycological culture, members of FDA's Dermatologic Drugs Advisory Committee concurred Sept. 23.